Investor relations

The investor pages that follow are your resource for financial information about Aastrom Biosciences, Inc. In this section you will find information about our current and historical share price, analyst coverage, SEC filings, an electronic version of our annual report and frequently asked questions as well as forms to request additional information.

View all »   RSSRecent Press Releases

Apr 9, 2014
Aastrom Reports Data and Safety Monitoring Board Recommendation to Continue ixCELL-DCM Clinical Trial

Apr 1, 2014
Aastrom Announces Appointments of Dr. Ross Tubo as Chief Scientific Officer and Dr. David Recker as Chief Medical Officer

View all »Events

Mar 26, 2014
Presentation at 2014 Regen Med Investor Day

Mar 13, 2014 at 4:30 PM ET
Aastrom Biosciences, Inc. Fourth Quarter 2013 Earnings Call

Stock Information
NASDAQ: ASTM
Price:
3.52
Change:
- 0.11
Day High:
3.75
Day Low:
3.50
Volume:
188,100
3:59 PM ET on Apr 17, 2014
Delayed at least 20 minutes.
Provided by eSignal.

Shareholder Tools